In 2016, decentralized fraud enforcement under the federal False Claims Act (FCA) recovered $ 2.5 billion spent on healthcare fraud without increasing spending. The FCA induces private citizens to pursue civil fraud claims on behalf of both themselves and the government, or qui tam ; incentives to pursue legal action for Medicaid fraud vary at the state level. We hypothesize that fraud enforcement agencies shift strategies as incentives for private citizens to monitor civil offenses rise. We find that state‐level FCAs did not increase the number of filed qui tam suits as incentives rose. Among filed cases, case quality did not change. Instead, agencies pursued fewer civil cases and case length increased. Our findings suggest potential qui tam plaintiffs are constrained by an ability to pursue cases, not incentives. Government‐led civil fraud enforcement may thus overestimate the capacity to decentralize fraud enforcement.
No takes yet. Share an insight, caveat, or question.
Nguyễn et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: